Suppression of cellular immunity by anesthesia and operation.
D000230:Adenocarcinoma / Q000276:immunology; D000328:Adult; D000768:Anesthesia, General / Q000009:adverse effects*; D000769:Anesthesia, Inhalation / Q000009:adverse effects; D000771:Anesthesia, Intravenous / Q000009:adverse effects; D002294:Carcinoma, Squamous Cell / Q000276:immunology; D004137:Dinitrochlorobenzene / Q000276:immunology; D006801:Humans; D007111:Immunity, Cellular; D007165:Immunosuppression Therapy; D008213:Lymphocyte Activation; D008545:Melanoma / Q000276:immunology; D008875:Middle Aged; D009369:Neoplasms / Q000276:immunology / Q000601:surgery*; D011379:Prognosis; D012509:Sarcoma / Q000276:immunology; D012882:Skin Tests; D013997:Time Factors
D004137:Dinitrochlorobenzene